189 related articles for article (PubMed ID: 23803252)
1. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of γ-H2AX during radiotherapy of head and neck cancer potentially allow for prediction of severe mucositis.
Kazmierska J; Barczak W; Winiecki T; Łuczewski Ł; Marciniak M; Suchorska W
Radiol Oncol; 2020 Feb; 54(1):96-102. PubMed ID: 32061167
[TBL] [Abstract][Full Text] [Related]
3. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer.
Fleckenstein J; Kühne M; Seegmüller K; Derschang S; Melchior P; Gräber S; Fricke A; Rübe CE; Rübe C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1465-72. PubMed ID: 20947264
[TBL] [Abstract][Full Text] [Related]
4. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
5. Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients.
Brzozowska A; Mlak R; Gołębiowski P; Małecka-Massalska T
Clin Transl Oncol; 2019 May; 21(5):615-620. PubMed ID: 30327938
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
[TBL] [Abstract][Full Text] [Related]
7. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Małecka-Massalska T
Cancer Biomark; 2018; 22(4):657-667. PubMed ID: 29865035
[TBL] [Abstract][Full Text] [Related]
8. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
9. Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer.
Werbrouck J; Duprez F; De Neve W; Thierens H
Int J Radiat Biol; 2011 Jan; 87(1):46-56. PubMed ID: 21142613
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-throughput γ-H2AX assay based on imaging flow cytometry.
Lee Y; Wang Q; Shuryak I; Brenner DJ; Turner HC
Radiat Oncol; 2019 Aug; 14(1):150. PubMed ID: 31438980
[TBL] [Abstract][Full Text] [Related]
12. Effect of dose rate on residual γ-H2AX levels and frequency of micronuclei in X-irradiated mouse lymphocytes.
Turner HC; Shuryak I; Taveras M; Bertucci A; Perrier JR; Chen C; Elliston CD; Johnson GW; Smilenov LB; Amundson SA; Brenner DJ
Radiat Res; 2015 Mar; 183(3):315-24. PubMed ID: 25738897
[TBL] [Abstract][Full Text] [Related]
13. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
[TBL] [Abstract][Full Text] [Related]
14. Mean frequency and relative fluorescence intensity measurement of γ-H2AX foci dose response in PBL exposed to γ-irradiation: An inter- and intra-laboratory comparison and its relevance for radiation triage.
Venkateswarlu R; Tamizh SG; Bhavani M; Kumar A; Alok A; Karthik K; Kalra N; Vijayalakshmi J; Paul SF; Chaudhury NK; Venkatachalam P
Cytometry A; 2015 Dec; 87(12):1138-46. PubMed ID: 26305808
[TBL] [Abstract][Full Text] [Related]
15. Measurement of γ-H2AX foci, miRNA-101, and gene expression as a means to quantify radiation-absorbed dose in cancer patients who had undergone radiotherapy.
Raavi V; Surendran J; Karthik K; Paul SFD; Thayalan K; Arunakaran J; Venkatachalam P
Radiat Environ Biophys; 2019 Mar; 58(1):69-80. PubMed ID: 30467642
[TBL] [Abstract][Full Text] [Related]
16. DNA double-strand break analysis by γ-H2AX foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients.
Goutham HV; Mumbrekar KD; Vadhiraja BM; Fernandes DJ; Sharan K; Kanive Parashiva G; Kapaettu S; Bola Sadashiva SR
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e607-12. PubMed ID: 22836053
[TBL] [Abstract][Full Text] [Related]
17. Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial.
Kia SJ; Basirat M; Saedi HS; Arab SA
BMC Complement Med Ther; 2021 Sep; 21(1):232. PubMed ID: 34521398
[TBL] [Abstract][Full Text] [Related]
18. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity.
Werbrouck J; De Ruyck K; Beels L; Vral A; Van Eijkeren M; De Neve W; Thierens H
Oncol Rep; 2010 Feb; 23(2):571-8. PubMed ID: 20043123
[TBL] [Abstract][Full Text] [Related]
19. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
